[Immunohistochemical examination oncogenic c-erb-b2, egf-r proteins and antioncogenic p53 protein in vulvar cancers HPV-16 positive and negative].
In vulvar cancers HPV 16 positive, HPV 16 negative, and vulvar and vaginal precancerous status (VIN, VAIN) immunohistochemical technik onko- and antioncogenic proteins were evaluated. The contrary correlation between HPV 16 presence and overexpression p53 were detected. It suggest the heterogenic etiology of these cancers. There was payed attention to high activity of virus replication and intensive virion production in VAIN. Nontreated vaginal lesion may make difficult to obtain a positive cervical HPV infection treatment.
Kedzia
W
W
I Katedry Ginekologii i Połoznictwa AM w Poznaniu.
Goździcka-Józefiak
A
A
Kedzia
H
H
Spaczyński
M
M
D000328:Adult; D000911:Antibodies, Monoclonal; D002465:Cell Movement / Q000502:physiology; D004279:DNA, Viral / Q000235:genetics; D066246:ErbB Receptors / Q000235:genetics*; D005260:Female; D016147:Genes, Tumor Suppressor / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D027383:Papillomaviridae / Q000235:genetics* / Q000276:immunology*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000235:genetics*; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D014771:Virion / Q000276:immunology / Q000378:metabolism; D014846:Vulvar Neoplasms / Q000235:genetics* / Q000276:immunology* / Q000473:pathology
D000911:Antibodies, Monoclonal; D004279:DNA, Viral; D066246:ErbB Receptors; D018719:Erb-b2 Receptor Tyrosine Kinases; D016159:Tumor Suppressor Protein p53